Clinical Trial of Sofosbuvir/Ribavirin for HCV Genotype 2-infected Japanese Patients
Not Applicable
Recruiting
- Conditions
- Chronic hepatitis C (genotype 2)
- Registration Number
- JPRN-UMIN000018554
- Lead Sponsor
- Gunma University and affiliated hospitals
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who have allergy to sofosbuvir or ribavirin Patients with renal dysfunction Patients with less than 12 g/dl hemoglobin Patients expecting a child and have a possibility of pregnancy or who are breast-feeding Patients taking contraindicated drug Patients whom the doctor in attendance judged as inappropriate
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method sustained virological response
- Secondary Outcome Measures
Name Time Method